These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

629 related items for PubMed ID: 22090514

  • 21. Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease.
    McFarland NR, Fan Z, Xu K, Schwarzschild MA, Feany MB, Hyman BT, McLean PJ.
    J Neuropathol Exp Neurol; 2009 May; 68(5):515-24. PubMed ID: 19525899
    [Abstract] [Full Text] [Related]

  • 22. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P.
    Proc Natl Acad Sci U S A; 2002 Aug 06; 99(16):10813-8. PubMed ID: 12122208
    [Abstract] [Full Text] [Related]

  • 23. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.
    Subbarayan MS, Hudson C, Moss LD, Nash KR, Bickford PC.
    J Neuroinflammation; 2020 Aug 15; 17(1):242. PubMed ID: 32799878
    [Abstract] [Full Text] [Related]

  • 24. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
    Maingay M, Romero-Ramos M, Carta M, Kirik D.
    Neurobiol Dis; 2006 Sep 15; 23(3):522-32. PubMed ID: 16806952
    [Abstract] [Full Text] [Related]

  • 25. Contribution of endogenous G-protein-coupled receptor kinases to Ser129 phosphorylation of alpha-synuclein in HEK293 cells.
    Sakamoto M, Arawaka S, Hara S, Sato H, Cui C, Machiya Y, Koyama S, Wada M, Kawanami T, Kurita K, Kato T.
    Biochem Biophys Res Commun; 2009 Jul 03; 384(3):378-82. PubMed ID: 19410557
    [Abstract] [Full Text] [Related]

  • 26. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
    Oliveras-Salvá M, Van der Perren A, Casadei N, Stroobants S, Nuber S, D'Hooge R, Van den Haute C, Baekelandt V.
    Mol Neurodegener; 2013 Nov 25; 8():44. PubMed ID: 24267638
    [Abstract] [Full Text] [Related]

  • 27. Tau knockout exacerbates degeneration of parvalbumin-positive neurons in substantia nigra pars reticulata in Parkinson's disease-related α-synuclein A53T mice.
    Jiao L, Zheng M, Duan J, Wu T, Li Z, Liu L, Xiang X, Tang X, He J, Li X, Zhang G, Ding J, Cai H, Lin X.
    FASEB J; 2020 Sep 25; 34(9):12239-12254. PubMed ID: 33000527
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease.
    Chen L, Feany MB.
    Nat Neurosci; 2005 May 25; 8(5):657-63. PubMed ID: 15834418
    [Abstract] [Full Text] [Related]

  • 34. Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease.
    Shen QQ, Jv XH, Ma XZ, Li C, Liu L, Jia WT, Qu L, Chen LL, Xie JX.
    Acta Pharmacol Sin; 2024 Feb 25; 45(2):268-281. PubMed ID: 37674042
    [Abstract] [Full Text] [Related]

  • 35. Downregulation of tyrosine hydroxylase phenotype after AAV injection above substantia nigra: Caution in experimental models of Parkinson's disease.
    Albert K, Voutilainen MH, Domanskyi A, Piepponen TP, Ahola S, Tuominen RK, Richie C, Harvey BK, Airavaara M.
    J Neurosci Res; 2019 Mar 25; 97(3):346-361. PubMed ID: 30548446
    [Abstract] [Full Text] [Related]

  • 36. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
    Gao HM, Zhang F, Zhou H, Kam W, Wilson B, Hong JS.
    Environ Health Perspect; 2011 Jun 25; 119(6):807-14. PubMed ID: 21245015
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
    Paumier KL, Luk KC, Manfredsson FP, Kanaan NM, Lipton JW, Collier TJ, Steece-Collier K, Kemp CJ, Celano S, Schulz E, Sandoval IM, Fleming S, Dirr E, Polinski NK, Trojanowski JQ, Lee VM, Sortwell CE.
    Neurobiol Dis; 2015 Oct 25; 82():185-199. PubMed ID: 26093169
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.